Cardiac surgery in three patients infected with the human immunodeficiency virus

Asako Namai; Masahiro Sakurai; Masatoshi Akiyama

doi:10.1007/s11748-008-0276-1

Cardiac surgery in three patients infected with the human immunodeficiency virus

Asako Namai, Masahiro Sakurai, Masatoshi Akiyama

MED - Medical Sciences

Research output: Contribution to journal › Article › peer-review

Abstract

Human immunodeficiency virus infection (HIV) is the fourth leading cause of death worldwide.1 Recently, the introduction of highly active antiretroviral therapy (HAART) improved the survival rate of HIV-infected patients.² However, the number of HIV-infected patients to be referred for cardiac surgery will increase because cardiovascular risk is increased with the use of HAART. Herein, we report three HIV-infected patients who underwent open heart surgery with cardiopulmonary bypass; we followed their progress by monitoring their CD4⁺ T-lymphocyte counts. Based on our experience, it seems that cardiopulmonary bypass does not accelerate progression of HIV disease.

Original language	English
Pages (from-to)	465-467
Number of pages	3
Journal	General thoracic and cardiovascular surgery
Volume	56
Issue number	9
DOIs	https://doi.org/10.1007/s11748-008-0276-1
Publication status	Published - 2008 Sep

Keywords

CD4 T-lymphocyte count
Highly active antiretroviral therapy
Human immunodeficiency virus infection
Open heart surgery with cardiopulmonary bypass

ASJC Scopus subject areas

Surgery
Pulmonary and Respiratory Medicine
Cardiology and Cardiovascular Medicine

UN SDGs

This output contributes to the following Sustainable Development Goal(s)

Access to Document

10.1007/s11748-008-0276-1

Fingerprint Dive into the research topics of 'Cardiac surgery in three patients infected with the human immunodeficiency virus'. Together they form a unique fingerprint.

Cite this

@article{d579de278b024c6c8b5e7bdfb20f4c4c,

title = "Cardiac surgery in three patients infected with the human immunodeficiency virus",

abstract = "Human immunodeficiency virus infection (HIV) is the fourth leading cause of death worldwide.1 Recently, the introduction of highly active antiretroviral therapy (HAART) improved the survival rate of HIV-infected patients.2 However, the number of HIV-infected patients to be referred for cardiac surgery will increase because cardiovascular risk is increased with the use of HAART. Herein, we report three HIV-infected patients who underwent open heart surgery with cardiopulmonary bypass; we followed their progress by monitoring their CD4+ T-lymphocyte counts. Based on our experience, it seems that cardiopulmonary bypass does not accelerate progression of HIV disease.",

keywords = "CD4 T-lymphocyte count, Highly active antiretroviral therapy, Human immunodeficiency virus infection, Open heart surgery with cardiopulmonary bypass",

author = "Asako Namai and Masahiro Sakurai and Masatoshi Akiyama",

year = "2008",

month = sep,

doi = "10.1007/s11748-008-0276-1",

language = "English",

volume = "56",

pages = "465--467",

journal = "General Thoracic and Cardiovascular Surgery",

issn = "1863-6705",

publisher = "Springer Japan",

number = "9",

}

TY - JOUR

T1 - Cardiac surgery in three patients infected with the human immunodeficiency virus

AU - Namai, Asako

AU - Sakurai, Masahiro

AU - Akiyama, Masatoshi

PY - 2008/9

Y1 - 2008/9

N2 - Human immunodeficiency virus infection (HIV) is the fourth leading cause of death worldwide.1 Recently, the introduction of highly active antiretroviral therapy (HAART) improved the survival rate of HIV-infected patients.2 However, the number of HIV-infected patients to be referred for cardiac surgery will increase because cardiovascular risk is increased with the use of HAART. Herein, we report three HIV-infected patients who underwent open heart surgery with cardiopulmonary bypass; we followed their progress by monitoring their CD4+ T-lymphocyte counts. Based on our experience, it seems that cardiopulmonary bypass does not accelerate progression of HIV disease.

AB - Human immunodeficiency virus infection (HIV) is the fourth leading cause of death worldwide.1 Recently, the introduction of highly active antiretroviral therapy (HAART) improved the survival rate of HIV-infected patients.2 However, the number of HIV-infected patients to be referred for cardiac surgery will increase because cardiovascular risk is increased with the use of HAART. Herein, we report three HIV-infected patients who underwent open heart surgery with cardiopulmonary bypass; we followed their progress by monitoring their CD4+ T-lymphocyte counts. Based on our experience, it seems that cardiopulmonary bypass does not accelerate progression of HIV disease.

KW - CD4 T-lymphocyte count

KW - Highly active antiretroviral therapy

KW - Human immunodeficiency virus infection

KW - Open heart surgery with cardiopulmonary bypass

UR - http://www.scopus.com/inward/record.url?scp=51749101495&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51749101495&partnerID=8YFLogxK

U2 - 10.1007/s11748-008-0276-1

DO - 10.1007/s11748-008-0276-1

M3 - Article

C2 - 18791674

AN - SCOPUS:51749101495

VL - 56

SP - 465

EP - 467

JO - General Thoracic and Cardiovascular Surgery

JF - General Thoracic and Cardiovascular Surgery

SN - 1863-6705

IS - 9

ER -

Cardiac surgery in three patients infected with the human immunodeficiency virus

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this